Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

References for PMC Articles for PubMed (Select 21415054)

1.

Molecular biomarker analyses using circulating tumor cells.

Punnoose EA, Atwal SK, Spoerke JM, Savage H, Pandita A, Yeh RF, Pirzkall A, Fine BM, Amler LC, Chen DS, Lackner MR.

PLoS One. 2010 Sep 8;5(9):e12517. doi: 10.1371/journal.pone.0012517.

2.

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.

Heiss MM, Murawa P, Koralewski P, Kutarska E, Kolesnik OO, Ivanchenko VV, Dudnichenko AS, Aleknaviciene B, Razbadauskas A, Gore M, Ganea-Motan E, Ciuleanu T, Wimberger P, Schmittel A, Schmalfeldt B, Burges A, Bokemeyer C, Lindhofer H, Lahr A, Parsons SL.

Int J Cancer. 2010 Nov 1;127(9):2209-21. doi: 10.1002/ijc.25423.

3.

Structural and functional characterization of the trifunctional antibody catumaxomab.

Chelius D, Ruf P, Gruber P, Plöscher M, Liedtke R, Gansberger E, Hess J, Wasiliu M, Lindhofer H.

MAbs. 2010 May-Jun;2(3):309-19. Epub 2010 May 16.

4.

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC.

J Clin Oncol. 2010 Jun 1;28(16):2784-95. doi: 10.1200/JCO.2009.25.6529. Epub 2010 Apr 19. Review. Erratum in: J Clin Oncol. 2010 Jul 20;28(21):3543.

5.

Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.

Tzankov A, Zlobec I, Went P, Robl H, Hoeller S, Dirnhofer S.

Leuk Lymphoma. 2010 Feb;51(2):199-212. doi: 10.3109/10428190903370338. Review.

PMID:
19925052
6.

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer.

Schmidt M, Scheulen ME, Dittrich C, Obrist P, Marschner N, Dirix L, Schmidt M, Rüttinger D, Schuler M, Reinhardt C, Awada A.

Ann Oncol. 2010 Feb;21(2):275-82. doi: 10.1093/annonc/mdp314. Epub 2009 Jul 24.

7.

Nuclear signalling by tumour-associated antigen EpCAM.

Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M, Gires O.

Nat Cell Biol. 2009 Feb;11(2):162-71. doi: 10.1038/ncb1824. Epub 2009 Jan 11.

PMID:
19136966
8.

Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E, Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I, Gebhard S, Pilch H, Gehrmann M, Lehr HA, Koelbl H, Hengstler JG, Schuler M.

Clin Cancer Res. 2008 Sep 15;14(18):5849-55. doi: 10.1158/1078-0432.CCR-08-0669.

9.

EpCAM expression in normal, non-pathological tissues.

Schmelzer E, Reid LM.

Front Biosci. 2008 Jan 1;13:3096-100.

PMID:
17981779
10.

EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features.

Laimer K, Fong D, Gastl G, Obrist P, Kloss F, Tuli T, Gassner R, Rasse M, Norer B, Spizzo G.

Oral Oncol. 2008 Jan;44(1):72-7. Epub 2007 Apr 5.

PMID:
17418618
11.

EpCAM (CD326) finding its role in cancer.

Baeuerle PA, Gires O.

Br J Cancer. 2007 Feb 12;96(3):417-23. Epub 2007 Jan 9. Review. Erratum in: Br J Cancer. 2007 May 7;96(9):1491.

12.

Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.

Fong D, Steurer M, Obrist P, Barbieri V, Margreiter R, Amberger A, Laimer K, Gastl G, Tzankov A, Spizzo G.

J Clin Pathol. 2008 Jan;61(1):31-5. Epub 2006 Jun 14.

PMID:
16775119
13.

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Baeuerle PA, Mueller-Holzner E, Marth C, Gastl G, Zeimet AG.

Gynecol Oncol. 2006 Nov;103(2):483-8. Epub 2006 May 6.

PMID:
16678891
14.

Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue.

Spizzo G, Gastl G, Obrist P, Fong D, Haun M, Grünewald K, Parson W, Eichmann C, Millinger S, Fiegl H, Margreiter R, Amberger A.

Cancer Lett. 2007 Feb 8;246(1-2):253-61. Epub 2006 Apr 18.

PMID:
16624485
15.

MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors.

Brischwein K, Schlereth B, Guller B, Steiger C, Wolf A, Lutterbuese R, Offner S, Locher M, Urbig T, Raum T, Kleindienst P, Wimberger P, Kimmig R, Fichtner I, Kufer P, Hofmeister R, da Silva AJ, Baeuerle PA.

Mol Immunol. 2006 Mar;43(8):1129-43. Epub 2005 Sep 1.

PMID:
16139892
16.

High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.

Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, von Castelberg B, Bart R, Stopatschinskaya S, Köchli OR, Haas P, Mross F, Zuber M, Dietrich H, Bischoff S, Mirlacher M, Sauter G, Gastl G.

Breast Cancer Res Treat. 2004 Aug;86(3):207-13.

PMID:
15567937
17.

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.

Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, Cole DJ, Gillanders WE.

Cancer Res. 2004 Aug 15;64(16):5818-24.

18.

The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.

Münz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O.

Oncogene. 2004 Jul 29;23(34):5748-58.

PMID:
15195135
19.

Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.

Varga M, Obrist P, Schneeberger S, Mühlmann G, Felgel-Farnholz C, Fong D, Zitt M, Brunhuber T, Schäfer G, Gastl G, Spizzo G.

Clin Cancer Res. 2004 May 1;10(9):3131-6.

20.

Wide metastatic spreading in infiltrating lobular carcinoma of the breast.

Ferlicot S, Vincent-Salomon A, Médioni J, Genin P, Rosty C, Sigal-Zafrani B, Fréneaux P, Jouve M, Thiery JP, Sastre-Garau X.

Eur J Cancer. 2004 Feb;40(3):336-41.

PMID:
14746850
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk